Remote Diabetes Care During Pandemic Lockdowns: Lessons Learned

Remote Diabetes Care During Pandemic Lockdowns: Lessons Learned and Future Implications

The COVID-19 pandemic fundamentally transformed healthcare delivery worldwide, forcing medical systems to rapidly pivot from traditional in-person care to remote solutions. Among the chronic conditions most affected by this seismic shift was diabetes management, where telemedicine provided the most convenient opportunity to communicate with patients and maintain delivery of care when physical doctor-patient visits became restricted. This unprecedented transition not only ensured continuity of care during a global crisis but also accelerated the adoption of digital health technologies that had been slowly gaining traction for decades. The lessons learned during this period have profound implications for the future of diabetes care, revealing both the tremendous potential and persistent challenges of remote healthcare delivery.

The Urgent Need for Remote Diabetes Care During COVID-19

The pandemic created a perfect storm of challenges for people living with diabetes. COVID-19-infected patients with diabetes had an increased risk of both mortality and debilitating sequelae, and this higher risk could be attenuated primarily by maintaining optimal control of the patient's glucose metabolism. This made consistent diabetes management more critical than ever, yet traditional in-person care became increasingly difficult and dangerous to access. Healthcare systems faced the dual challenge of protecting vulnerable patients from viral exposure while ensuring they received the ongoing monitoring and support essential for preventing serious complications.

The response was swift and comprehensive. The COVID-19 pandemic led to rapid widescale adoption of telehealth for diabetes management by rendering in-person care less accessible and less safe. What had previously been a gradual evolution toward digital health suddenly became an urgent necessity, with healthcare providers, patients, and regulatory bodies all adapting at unprecedented speed to enable remote care delivery.

The Rapid Expansion of Telemedicine for Diabetes Management

Telemedicine became a crucial part of health care as a method to facilitate doctor-patient interaction, and due to technological developments and the incremental acquisition of experience in its use, telemedicine's advantages and cost-effectiveness led to it being recognised as specifically relevant to diabetology. However, the pandemic created new challenges for healthcare systems and the rate of development of digital services started to grow exponentially.

The scale of this transformation was remarkable. The proportion of telehealth users increased from 38.7% in 2018-2019 to 91.5% in 2020-2021 in one large integrated health system. This dramatic surge represented not just a temporary workaround but a fundamental reimagining of how diabetes care could be delivered. Healthcare providers who had never conducted a video visit suddenly found themselves managing entire patient panels remotely, while patients who had always relied on in-person appointments learned to navigate digital platforms and share health data electronically.

Key Advantages of Remote Diabetes Care

The shift to telemedicine revealed numerous benefits that extended beyond simply maintaining care during lockdowns. These advantages have important implications for how diabetes care might be structured in the future.

Enhanced Accessibility and Safety

Remote care eliminated many traditional barriers to accessing healthcare. Patients no longer needed to arrange transportation, take time off work, or navigate crowded waiting rooms. For people with diabetes living in rural areas or those with mobility limitations, telemedicine opened doors that had previously been closed. The safety benefits during the pandemic were particularly crucial, allowing vulnerable patients to receive care without risking exposure to COVID-19 in healthcare settings.

Real-Time Continuous Glucose Monitoring and Data Sharing

Perhaps the most transformative aspect of remote diabetes care was the integration of continuous glucose monitoring (CGM) technology with telemedicine platforms. Continuous glucose monitoring is a diabetes technology that provides 24-hour glucose monitoring and is associated with improved clinical outcomes, including decreased rates of hypoglycemia and lower hemoglobin A1c, and CGM use has increased due to ease of use and its ability to allow patients to share data with providers during virtual visits.

Successful linking of devices and accounts enabled continuous, passive data-sharing from participants' CGM devices to research teams' platforms, made possible by Bluetooth-enabled continuous glucose monitoring and blood glucose monitoring devices as well as multiple diabetes data-sharing platforms. This capability transformed the nature of diabetes care, shifting from episodic assessments based on periodic blood sugar checks to continuous monitoring that provided a comprehensive picture of glucose patterns throughout the day and night.

The benefits of this technology extended beyond clinical metrics. The presence of at least one remote monitor was associated with lower mean glucose values, more glucose values in the 70- to 180-mg/dL range, correspondingly fewer glucose values representing hypoglycemia and hyperglycemia, and significantly more device utilization, with real-time sharing and following of CGM data associated with improved device utilization and glycemic parameters.

Increased Patient Engagement and Self-Management

Remote care models often led to more frequent touchpoints between patients and healthcare providers, even if individual interactions were shorter. This increased communication encouraged better self-management behaviors and helped patients feel more supported in their daily diabetes management. The ability to quickly consult with providers about concerning glucose patterns or medication adjustments meant that problems could be addressed before they escalated into serious complications.

Access to telephone and video telemedicine throughout the early COVID-19 pandemic was associated with patients' continued engagement in recommended diabetes care. This engagement translated into tangible health outcomes, with many patients maintaining or even improving their diabetes control despite the challenges of the pandemic.

Maintained Quality of Care

One of the most important findings from pandemic-era research was that telemedicine could maintain quality of care comparable to in-person visits. Patients utilizing telemedicine were no less likely to meet diabetes composite quality measures compared to before the pandemic, whereas patients utilizing in-person care alone were less likely to meet these measures. This finding challenged assumptions that remote care would necessarily be inferior to traditional face-to-face encounters.

Patients with diabetes in a large academic medical center who used telemedicine achieved similar quality outcomes compared to before the pandemic; however, patients who utilized only in-person care saw a decline in the quality outcome ascertainment. This suggests that telemedicine not only maintained care quality but may have actually helped buffer against pandemic-related disruptions that affected traditional care delivery.

Clinical Outcomes: Evidence from the Pandemic Period

The rapid implementation of telemedicine for diabetes care during the pandemic provided a unique opportunity to evaluate its effectiveness at scale. Research from this period yielded valuable insights into how remote care impacts clinical outcomes.

Glycemic Control Improvements

Multiple studies documented improvements in glycemic control among patients receiving telemedicine-based diabetes care. Use of telemedicine is related to significant improvements in HbA1c for patients with type 1 and type 2 diabetes, compared to standard care, along with patient-reported satisfaction, with a meta-analysis from China of 35 randomized controlled trials in patients with type 2 diabetes showing a small, but statistically significant, decrease in HbA1c by 0.37% in the telemedicine group.

In specific pandemic-era studies, the results were even more impressive. A study in Saudi Arabia showed a significant positive impact of telemedicine care on glycemic control among high-risk patients with type 2 diabetes during the COVID-19 pandemic, with HbA1c decreasing significantly from 9.98 ±1.33 to 8.32 ±1.31% over a period of 4 months. This substantial reduction demonstrated that telemedicine could be particularly effective for patients with poorly controlled diabetes who needed intensive management.

Remote monitoring of type 2 diabetes patients resulted in average 3- and 6-month HbA1c reductions of 1.3% and 1.2% respectively in the pre-COVID-19 period, compared to 2.0% and 2.2% during the COVID-19 period, with the percentage of patients who achieved HbA1c goals at 41.7% in the pre-COVID-19 period versus 54% during the COVID-19 period. These findings suggest that the intensive focus on remote monitoring during the pandemic may have actually enhanced outcomes beyond what was achieved with pre-pandemic telemedicine approaches.

Benefits for Special Populations

Gestational diabetes is another field where telemedicine has beneficial effects, as during the pandemic physical visits were difficult to make and risky for a pregnant woman, making telemedicine a safe way to monitor women with gestational diabetes, confirmed in a meta-analysis of 32 randomized controlled trials showing that the use of telemedicine, compared to standard care, for the follow-up of women with gestational diabetes during the pandemic was associated with significant improvements in glycemic control.

This finding was particularly important given the risks that both COVID-19 and poorly controlled diabetes pose during pregnancy. The ability to provide effective care remotely helped protect both mothers and babies during a vulnerable time.

Downstream Effects on Care Adherence

Rates of having an HbA1c measurement during the second year of the COVID-19 pandemic were statistically significantly higher among patients with telemedicine exposure than those with no visits, at 91.0% for video visits, 90.5% for telephone visits, and 86.7% for no visits. This finding suggests that telemedicine helped maintain adherence to recommended monitoring schedules, which is crucial for preventing long-term complications.

However, the picture was not uniformly positive. During versus pre-pandemic, adherence to all care processes declined in both telehealth users and non-telehealth users, and in telehealth users, average HbA1c, systolic blood pressure, and creatinine worsened during versus pre-COVID-19, while LDL cholesterol improved. This mixed picture highlights that while telemedicine helped mitigate pandemic-related disruptions, it could not completely eliminate all negative impacts on diabetes care.

Significant Challenges and Barriers to Remote Diabetes Care

Despite the many successes of remote diabetes care during the pandemic, significant challenges emerged that must be addressed to ensure equitable and effective telemedicine implementation going forward.

The Digital Divide and Technology Barriers

One of the most persistent challenges was unequal access to the technology required for telemedicine. Data from the pandemic demonstrate that access to telehealth for people with diabetes is significantly affected by individual demographics and local care delivery systems, the perceived utility of telehealth may vary among people with diabetes based on demographic and clinical characteristics, and overall receipt of care for diabetes during the pandemic has therefore been unevenly distributed.

Not all patients had reliable internet connections, smartphones, or computers capable of supporting video visits. Older adults, rural populations, and those with lower socioeconomic status were disproportionately affected by these barriers. Lack of internet or computer access in the patient's home can be a barrier to virtual CGM use, though some healthcare systems provide iPads to patients free of charge that could be configured for remote CGM data sharing.

Beyond hardware and connectivity issues, many patients struggled with the technical skills required to navigate telemedicine platforms, upload glucose data, or troubleshoot connectivity problems. Healthcare systems had to rapidly develop patient education programs and technical support services to help patients overcome these barriers, but gaps remained.

Data Privacy and Security Concerns

The rapid expansion of telemedicine raised important questions about data privacy and security. Transmitting sensitive health information electronically requires robust security measures to protect patient confidentiality and comply with regulations like HIPAA. Healthcare systems had to quickly implement secure platforms and educate both providers and patients about best practices for protecting health information during remote encounters.

The integration of CGM data with electronic health records and telemedicine platforms added another layer of complexity. Solutions utilize consensus recommendations including a data pull strategy, a CGM account linkage strategy that simultaneously establishes patient identity and acquires consent, and data readily displayed in a dedicated space in the EHR, building on recommendations by providing a platform through the EHR to view interactive data visualizations and a pathway for patients to self-authenticate their identity and allow data sharing using their account credentials.

Limitations of Physical Examinations

While many aspects of diabetes care can be effectively managed remotely, some assessments still require in-person visits. Current guidelines from the American Diabetes Association recommend that people with diabetes have at least annual checks to measure blood pressure, HbA1c, eye and foot examinations, body mass index, serum creatinine, and urine-albumin-to-creatinine ratio. Comprehensive foot examinations, detailed eye assessments, and certain physical measurements are difficult or impossible to conduct virtually.

This limitation meant that purely remote care models were insufficient for comprehensive diabetes management. Patients still needed periodic in-person visits for complete assessments, creating challenges during lockdown periods when such visits were restricted or risky.

Provider Challenges and Workflow Disruptions

Many providers are overwhelmed by the various options available and large influx of data received from CGM systems and other remote monitoring technologies. The transition to telemedicine required providers to learn new platforms, adapt their clinical workflows, and develop skills for conducting effective virtual visits. The volume of data generated by continuous monitoring devices created both opportunities and challenges, as providers needed efficient systems for reviewing and acting on this information.

Successful implementation requires local infrastructure and consistent patient-provider interactions, although increased healthcare provider workloads may affect sustainability. The additional time required to review remote monitoring data, respond to patient messages, and manage technical issues added to already heavy provider workloads, raising questions about the long-term sustainability of intensive remote monitoring programs.

Variable Outcomes and Implementation Challenges

Not all telemedicine implementations achieved positive results. Some studies found that only 12.3% of patients had a decreased HbA1c level, whereas 15.7% had worsened control, and 72% maintained their HbA1c level, with reasons for these outcomes including the rapid implementation with no structured approach, limited access to nutritious food, and the psychological impact of the pandemic.

These mixed results highlight that simply providing telemedicine technology is not sufficient—successful implementation requires careful planning, adequate support systems, and attention to the broader social determinants of health that affect diabetes management.

The Role of Continuous Glucose Monitoring in Remote Care Success

Continuous glucose monitoring emerged as a cornerstone technology enabling effective remote diabetes care during the pandemic. The ability to continuously track glucose levels and share this data remotely transformed what was possible in virtual care settings.

Technical Capabilities and Data Integration

Population-level analytics have been developed within commercially available diabetes data platforms to rapidly identify which patients exhibit high-risk data patterns during a given timeframe, and remote monitoring enhanced by population analytics has the potential to facilitate more person-centered care and to improve health outcomes by enabling clinicians to provide the right care at the right time to each patient.

Modern CGM systems offer sophisticated features that support remote care. Devices can transmit data automatically to cloud-based platforms, generate alerts for concerning glucose patterns, and provide detailed reports that help both patients and providers understand glucose trends. Making CGM data available in the EHR may vastly improve diabetes care in outpatient settings by allowing clinicians to access and interpret data more efficiently and provide their patients with more relevant education.

Data Sharing with Family and Caregivers

An important feature of CGM technology is the ability to share glucose data with family members or caregivers, which proved particularly valuable during the pandemic. Continuous glucose monitoring allows a person with diabetes to see their glucose levels continuously and to receive predictive alerts, and a smartphone data-sharing app allows the person with diabetes to share continuous glucose numbers with others and to receive predictive alerts of impending hypo- and hyperglycemia.

Interventions addressing data sharing were feasible and associated with high self-reported satisfaction for people with diabetes and their care partners as well as high adherence to CGM at mean 96%. This capability provided peace of mind for both patients and their loved ones, particularly for older adults or those at higher risk for severe hypoglycemia.

Standardized Reporting and Clinical Decision Support

To manage the large volume of data generated by CGM systems, standardized reporting formats became essential. An international expert consensus panel recommended a common set of CGM metrics and the Ambulatory Glucose Profile format as the standard reporting structure, developed by an expert panel of diabetes specialists and customized for insulin pumps or injection therapy.

These standardized reports made it easier for providers to quickly assess glucose control during virtual visits and make informed treatment decisions. The ability to view comprehensive glucose data in a standardized format helped overcome some of the limitations of not being able to conduct in-person assessments.

Lessons Learned: Key Insights from Pandemic-Era Remote Diabetes Care

The pandemic served as an unplanned but comprehensive test of remote diabetes care at scale. The experience yielded valuable lessons that should inform future healthcare delivery models.

The Importance of Equitable Access

Perhaps the most critical lesson was that technology alone cannot solve healthcare access problems if not everyone can use that technology. To ensure equitable access to diabetes care, legislation should provide more flexibility regarding geographic boundaries and telehealth delivery modes, including supporting both audio-only and video-audio visits to accommodate patients with varying levels of technology access.

Healthcare systems must proactively address digital literacy gaps, provide devices and internet access to those who lack them, and ensure that telemedicine platforms are designed with accessibility in mind. The goal should be to expand access to care, not to create new barriers that exclude vulnerable populations.

The Need for Robust Data Security Infrastructure

The rapid expansion of telemedicine highlighted the critical importance of secure data transmission and storage systems. Healthcare organizations learned that they needed to invest in robust cybersecurity measures, train staff on data protection protocols, and ensure that all telemedicine platforms met regulatory requirements for protecting patient information.

Going forward, data security cannot be an afterthought but must be built into telemedicine systems from the ground up. Patients need confidence that their sensitive health information will be protected when shared electronically.

The Value of Hybrid Care Models

Telemedicine alone was less effective for patients with complex comorbidities, suggesting that a combined approach with in-person visits may be more effective. The pandemic experience demonstrated that the most effective approach combines the convenience and accessibility of telemedicine with the comprehensive assessment capabilities of in-person care.

Future research to investigate the ideal balance between in-person and telehealth visits in diabetes care is warranted to enhance the quality of diabetes care and to optimize diabetes outcomes. Different patients may need different ratios of virtual to in-person visits based on their clinical complexity, stability of glucose control, and individual preferences.

The Importance of Structured Implementation

The variable outcomes observed across different telemedicine implementations highlighted that success requires more than just providing technology. Effective remote diabetes care requires structured protocols, adequate training for both providers and patients, technical support systems, and integration with existing clinical workflows.

Telemedicine has potential to replace routine in-person visits for diabetes management in rural areas, demonstrating significant improvements in HbA1c levels, medication adherence, and timely care management support, though future research should focus on randomized controlled trials in rural settings, hybrid care models that optimize in-person visit frequency and remote monitoring, and addressing technological challenges such as broadband access and platform usability.

The Role of Patient and Provider Education

Both patients and providers needed education and support to effectively use telemedicine and remote monitoring technologies. Healthcare systems that invested in comprehensive training programs and ongoing technical support achieved better outcomes than those that simply deployed technology without adequate preparation.

Telehealth-related technology design needs to consider user experience and user-centered design to optimize the use of telehealth; a person-oriented telehealth workflow has the potential to address concerns about the negative effects of telehealth visits on the quality of diabetes. Technology platforms must be intuitive and designed with the needs of diverse users in mind.

Future Directions: Integrating Remote Care into Standard Practice

The pandemic accelerated the adoption of telemedicine by years, if not decades. As healthcare systems move beyond the acute crisis phase, the challenge is to thoughtfully integrate the lessons learned into sustainable models of care that improve outcomes while remaining accessible and equitable.

Developing Sustainable Hybrid Care Models

The future of diabetes care likely lies in hybrid models that strategically combine in-person and virtual care. Telehealth use increased during the pandemic and alleviated some of the observed declines in routine diabetes care and management. The key is determining which services are best delivered remotely and which require in-person visits.

Routine medication adjustments, diabetes education, and review of glucose data can often be effectively handled via telemedicine, while comprehensive physical examinations, foot assessments, and initial evaluations may be better suited to in-person visits. Healthcare systems should develop protocols that specify when each modality is most appropriate, while remaining flexible enough to accommodate individual patient needs and preferences.

Leveraging Advanced Technologies

In order to create state-of-the-art and resilient health care systems, telemedicine and IT solutions such as artificial intelligence or robotics developed during the COVID-19 pandemic ought to be employed more widely in health care, and utilizing these methods could be crucial not only in the post pandemic era but also under potential public health emergencies.

Artificial intelligence and machine learning algorithms could help providers manage the large volumes of data generated by continuous monitoring devices, identifying patterns and alerting providers to patients who need intervention. Automated insulin delivery systems that integrate CGM data with insulin pumps represent another frontier in diabetes technology that could be enhanced through remote monitoring capabilities.

Addressing Regulatory and Reimbursement Challenges

Many of the regulatory flexibilities that enabled rapid telemedicine expansion during the pandemic were temporary emergency measures. The health economics of telemedicine proposals should be formally evaluated as the field continues to collect and analyze data related to the large-scale use of telehealth within diabetes care, and whether telehealth in its current or in a future, more optimized state might improve the cost-effectiveness of care for high-risk populations.

Policymakers must decide which flexibilities to make permanent and how to structure reimbursement to support sustainable telemedicine programs. This includes addressing questions about interstate licensure for providers, reimbursement parity between in-person and virtual visits, and coverage for remote monitoring services.

Expanding Access to Underserved Populations

Remote care has particular potential to improve diabetes outcomes in rural and underserved communities that have historically faced barriers to accessing specialty care. Out of every three individuals affected by diabetes, one lives in a rural setting, and rural populations face many challenges that can prevent better glycemic control, such as geographic isolation, health worker shortages, and lower health spending compared to urban populations.

Telemedicine can help bridge these gaps by connecting patients in remote areas with diabetes specialists, providing education and support that might otherwise be unavailable. However, this requires addressing the infrastructure challenges that limit technology access in rural areas, including broadband internet availability.

Fostering Interdisciplinary Remote Care Teams

Pharmacy interactions can be scheduled in-between provider visits to assist with insulin and noninsulin medication titration allowing for faster and more aggressive glycemic regulation, and nutritionists can use CGM data to improve patient's nutritional choices and carbohydrate counting skills and develop strategies to improve lifestyle behaviors that decrease blood glucose variability.

Remote care enables more flexible collaboration among interdisciplinary team members. Diabetes educators, pharmacists, nutritionists, and mental health professionals can all contribute to patient care through virtual visits, potentially providing more comprehensive support than traditional models where patients primarily see only their physician.

Continuing Research and Quality Improvement

Increasing evidence gathered suggests a crucial role of telemedicine in improving health system outcomes in many developed countries. However, many questions remain about optimal implementation strategies, long-term outcomes, and cost-effectiveness.

Healthcare systems should continue to rigorously evaluate their telemedicine programs, collecting data on clinical outcomes, patient satisfaction, provider experience, and costs. This ongoing assessment will help refine approaches and identify best practices that can be shared across organizations.

Practical Recommendations for Healthcare Systems and Providers

Based on the lessons learned during the pandemic, healthcare organizations and individual providers can take concrete steps to optimize remote diabetes care delivery.

For Healthcare Systems

• Invest in robust telemedicine infrastructure: Ensure platforms are secure, user-friendly, and integrate seamlessly with electronic health records and remote monitoring devices.
• Provide comprehensive training: Develop training programs for both clinical staff and patients that cover technical skills, best practices for virtual visits, and troubleshooting common problems.
• Establish technical support services: Create dedicated support teams to help patients and providers resolve technology issues quickly.
• Address the digital divide: Develop programs to provide devices, internet access, and digital literacy training to patients who lack these resources.
• Create clear protocols: Develop evidence-based guidelines for when to use telemedicine versus in-person care, and how to integrate remote monitoring data into clinical decision-making.
• Monitor outcomes and equity: Regularly assess whether telemedicine programs are achieving desired clinical outcomes and whether all patient populations are benefiting equitably.

For Individual Providers

• Develop virtual visit skills: Learn techniques for building rapport, conducting assessments, and providing education effectively in virtual settings.
• Master remote monitoring tools: Become proficient with CGM data platforms and learn to efficiently review and interpret continuous glucose data.
• Communicate proactively: Reach out to patients between scheduled visits when remote monitoring data suggests intervention is needed.
• Personalize care plans: Work with each patient to determine the right balance of virtual and in-person care based on their individual needs, preferences, and technology access.
• Engage interdisciplinary teams: Leverage the expertise of diabetes educators, pharmacists, and other team members through virtual consultations.
• Stay current with technology: Keep up with evolving diabetes technologies and telemedicine capabilities to provide patients with the most effective care options.

The Patient Perspective: Empowerment and Engagement

While much attention has focused on the clinical and operational aspects of remote diabetes care, the patient experience is equally important. The pandemic forced many patients to become more actively engaged in their diabetes management, with mixed results.

For some patients, remote care and continuous monitoring technologies were empowering, providing them with more information about their glucose patterns and more frequent contact with their healthcare team. The ability to quickly consult with providers about concerns without scheduling an in-person appointment reduced anxiety and helped patients feel more supported.

However, other patients found the constant stream of glucose data overwhelming or felt that virtual visits lacked the personal connection of face-to-face encounters. Some struggled with the technology or felt isolated when in-person support was unavailable.

These varied experiences highlight the importance of patient-centered care that considers individual preferences, capabilities, and circumstances. The goal should be to use technology to enhance the patient-provider relationship and support self-management, not to replace human connection or create additional burdens.

Conclusion: A Transformed Landscape for Diabetes Care

The COVID-19 pandemic fundamentally transformed diabetes care delivery, accelerating the adoption of telemedicine and remote monitoring technologies in ways that would have taken years under normal circumstances. While born of necessity, this transformation revealed significant potential for improving access to care, maintaining quality outcomes, and supporting patient self-management.

This demonstration of the incorporation of telemedicine as a mode of ambulatory care in addition to in-person visits during the early pandemic is an early indicator of the promise of telemedicine to deliver high-quality care across populations. The evidence gathered during this period provides a strong foundation for continued integration of remote care into standard diabetes management.

However, realizing the full potential of remote diabetes care requires addressing persistent challenges around equitable access, data security, provider training, and optimal integration of virtual and in-person care. Healthcare systems must build on the lessons learned during the pandemic to create sustainable, patient-centered models that leverage technology to improve outcomes while ensuring that no one is left behind.

The future of diabetes care will likely be hybrid, combining the best aspects of traditional in-person care with the convenience, accessibility, and enhanced monitoring capabilities of telemedicine. By thoughtfully implementing these integrated approaches, healthcare systems can provide more responsive, personalized care that helps people with diabetes achieve better outcomes and improved quality of life.

As we move forward, continued research, quality improvement efforts, and policy development will be essential to refine these approaches and ensure they benefit all patients. The pandemic provided an unprecedented opportunity to test remote care at scale—now the challenge is to build on that experience to create a more accessible, equitable, and effective healthcare system for people living with diabetes.

For more information on diabetes management and telemedicine, visit the American Diabetes Association, explore resources from the Centers for Disease Control and Prevention, or learn about continuous glucose monitoring technology at The Endocrine Society.